Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine

• Published in: American journal of veterinary research Vol. 76; no. 10; pp. 913 - 920
• Main Authors: Smith, Billy I, Rieger, Randall H, Dickens, Charlene M, Schultz, Ronald D, Aceto, Helen
• Format: Journal Article
• Language: English
• Published: United States American Veterinary Medical Association 01.10.2015
• Subjects: Animals; Antibodies, Viral - blood; Antibody Formation; Bovine Virus Diarrhea-Mucosal Disease - immunology; Bovine Virus Diarrhea-Mucosal Disease - prevention & control; Cattle; Dairying; Diarrhea Virus 1, Bovine Viral - immunology; Diarrhea Virus 2, Bovine Viral - immunology; Female; Herpesvirus 1, Bovine - immunology; Infectious Bovine Rhinotracheitis - immunology; Infectious Bovine Rhinotracheitis - prevention & control; Pregnancy; Pregnancy, Animal; Vaccination - veterinary; Vaccines, Inactivated - immunology; Viral Vaccines - administration & dosage; Viral Vaccines - immunology
• ISSN: 0002-9645; 1943-5681
• DOI: 10.2460/ajvr.76.10.913

OBJECTIVE To determine the effect of a commercially available multivalent killed virus vaccine on serum neutralizing (SN) and colostrum neutralizing (CN) antibodies against bovine herpesvirus (BHV) type 1 and bovine viral diarrhea virus (BVDV) types 1 and 2 in pregnant dairy cattle. ANIMALS 49 Holstein dairy cattle. PROCEDURES 25 cattle were vaccinated (IM injection) at least 60 days prior to calving (ie, at the end of the lactation period or according to the expected calving date for heifers) and again 5 weeks later. The remaining 24 cattle were not vaccinated (control group). Titers of SN antibodies were measured at the 5-week time point. Titers of SN and CN antibodies were measured at parturition. RESULTS 5 weeks after initial vaccination, titers of SN antibodies against BHV-1 and BVDV types 1 and 2 were 1:512, 1:128, and 1:2,048, respectively, in vaccinates and 1:64, 1:128, and 1:64, respectively, in unvaccinated controls. Equivalent SN antibody titers at parturition were 1:256, 1:64, and 1:512, respectively, in vaccinates and 1:128, 1:128, and 1:64, respectively, in controls. Median titers of CN antibodies against BHV-1 and BVDV types 1 and 2 were 1:1,280, 1:10,240, and 1:20,480, respectively, in vaccinates and 1:80, 1:1,280, and 1:2,560, respectively, in controls. CONCLUSIONS AND CLINICAL RELEVANCE Titers of antibodies against viral respiratory pathogens were significantly enhanced in both serum (BHV-1 and BVDV type 2) and colostrum (BHV-1 and BVDV types 1 and 2) in cattle receiving a killed virus vaccine (with no adverse reactions) before parturition. To maximize protection of bovine neonates, this method of vaccination should be considered.